Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy
NCT00860093
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
135
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor Corporate Business Decision
Conditions
Nephrolithiasis
Interventions
OTHER:
placebo
DRUG:
MPC-5971
Sponsor
Mission Pharmacal